PDT Partners LLC Makes New $3.35 Million Investment in West Pharmaceutical Services, Inc. $WST

PDT Partners LLC bought a new stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST) during the 2nd quarter, Holdings Channel reports. The fund bought 9,332 shares of the medical instruments supplier’s stock, valued at approximately $3,350,000.

A number of other institutional investors also recently bought and sold shares of the stock. Addison Advisors LLC bought a new stake in West Pharmaceutical Services during the second quarter worth about $28,000. Avalon Trust Co bought a new stake in shares of West Pharmaceutical Services in the second quarter worth approximately $28,000. Elyxium Wealth LLC bought a new position in West Pharmaceutical Services in the fourth quarter valued at about $25,000. Bayban bought a new stake in West Pharmaceutical Services during the fourth quarter valued at approximately $27,000. Finally, DV Equities LLC bought a new position in West Pharmaceutical Services in the 4th quarter worth $28,000. 93.90% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on WST shares. Barclays upgraded West Pharmaceutical Services from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $310.00 to $400.00 in a research report on Tuesday, June 9th. Stephens reiterated an “overweight” rating and issued a $360.00 target price on shares of West Pharmaceutical Services in a report on Tuesday, June 2nd. TD Cowen reiterated a “buy” rating on shares of West Pharmaceutical Services in a report on Wednesday, July 15th. Evercore reissued an “outperform” rating and issued a $425.00 price target on shares of West Pharmaceutical Services in a report on Monday, July 27th. Finally, Citigroup lifted their price target on West Pharmaceutical Services from $400.00 to $412.00 and gave the stock a “buy” rating in a research report on Monday, August 3rd. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $368.08.

West Pharmaceutical Services Stock Up 0.6%

NYSE WST opened at $350.68 on Thursday. The company has a quick ratio of 2.12, a current ratio of 2.82 and a debt-to-equity ratio of 0.07. The firm has a market cap of $24.68 billion, a PE ratio of 44.90, a P/E/G ratio of 2.44 and a beta of 1.15. The business’s fifty day simple moving average is $349.99 and its 200-day simple moving average is $302.68. West Pharmaceutical Services, Inc. has a 52 week low of $223.83 and a 52 week high of $386.00.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings data on Thursday, July 23rd. The medical instruments supplier reported $2.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.08 by $0.29. The firm had revenue of $872.30 million during the quarter, compared to the consensus estimate of $839.98 million. West Pharmaceutical Services had a return on equity of 20.11% and a net margin of 16.98%.The company’s quarterly revenue was up 13.8% on a year-over-year basis. During the same period last year, the company earned $1.84 EPS. West Pharmaceutical Services has set its Q3 2026 guidance at 2.140-2.240 EPS and its FY 2026 guidance at 8.850-9.050 EPS. As a group, equities analysts anticipate that West Pharmaceutical Services, Inc. will post 8.93 earnings per share for the current year.

West Pharmaceutical Services Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, August 5th. Shareholders of record on Wednesday, July 29th were paid a $0.22 dividend. The ex-dividend date was Wednesday, July 29th. This represents a $0.88 dividend on an annualized basis and a yield of 0.3%. West Pharmaceutical Services’s dividend payout ratio (DPR) is currently 11.27%.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc is a global developer and manufacturer of components, systems and services that enable the containment and delivery of injectable drugs. The company focuses on high-quality packaging and delivery solutions for the pharmaceutical and biotech industries, producing primary drug packaging components and specialized drug delivery devices used for vaccines, biologics and other injectable therapies. West is known for its elastomeric closures, seals and polymer components that maintain sterility and compatibility with sensitive drug formulations.

In addition to component manufacturing, West provides engineered delivery systems and support services across the product lifecycle.